Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RICKY PAUL GANIM

Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology

NPI
1295843019
CMS profile
240597
Location
HUMBLE, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$9,802.19

134 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Long term medical supply or device loan $5,000.00 1
Food and Beverage $3,302.19 131
Consulting Fee $1,500.00 2

By paying entity

PY2024 · entire year · sorted by reported total

Page 3 of 3; records 101–134 of 134 matching records. This page contains 34 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RICKY PAUL GANIM

NPI 1295843019 · CMS profile ID 240597

Allopathic & Osteopathic Physicians / Internal Medicine / Interventional Cardiology

HUMBLE, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–134 of 134 matching records. This page contains 34 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1295843019?year=2024&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RICKY PAUL GANIM, NPI 1295843019, CMS profile ID 240597. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–134 of 134 matching records. This page contains 34 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1295843019?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). RICKY PAUL GANIM, NPI 1295843019, CMS profile ID 240597. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–134 of 134 matching records. This page contains 34 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1295843019?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
RICKY PAUL GANIM, NPI 1295843019, CMS profile ID 240597, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–134 of 134 matching records. This page contains 34 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1295843019?year=2024&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

134 matching records · $9,802.19 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 134 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–134 of 134.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ShockWave Medical, Inc $23.8903/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152983582 CMS
Novartis Pharmaceuticals Corporation $10.9303/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086873633 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $11.9003/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1080687580 CMS
AngioDynamics, Inc. $2.9003/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1095075649 CMS
Merck Sharp & Dohme LLC $21.9803/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141889042 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $7.0503/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1080687578 CMS
AngioDynamics, Inc. $9.2603/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1095075645 CMS
Novartis Pharmaceuticals Corporation $13.8703/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086873641 CMS
PFIZER INC. $29.2403/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131234038 CMS
Esperion Therapeutics, Inc. $21.6603/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1129435452 CMS
AngioDynamics, Inc. $7.5102/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1095075642 CMS
Novartis Pharmaceuticals Corporation $13.1102/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086873639 CMS
Abbott Laboratories $128.7802/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124968266 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $8.1502/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1080687576 CMS
Boston Scientific Corporation $29.5202/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092624741 CMS
ShockWave Medical, Inc $21.0002/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152984286 CMS
Boston Scientific Corporation $23.0902/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092624737 CMS
Novartis Pharmaceuticals Corporation $24.7502/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086873625 CMS
Abbott Laboratories $91.9902/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124968262 CMS
AngioDynamics, Inc. $32.3202/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1095075637 CMS
AngioDynamics, Inc. $18.7302/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1095075634 CMS
CARDIVA MEDICAL, INC. $21.4602/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143855093 CMS
CARDIVA MEDICAL, INC. $18.4002/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143855095 CMS
E.R. Squibb & Sons, L.L.C. $20.0001/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101243138 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $4.4001/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1080687572 CMS
Becton, Dickinson and Company $13.3901/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1127612872 CMS
Boston Scientific Corporation $20.7701/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092624731 CMS
AngioDynamics, Inc. $6.3101/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1095075630 CMS
Merck Sharp & Dohme LLC $24.7201/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141937399 CMS
AngioDynamics, Inc. $2.9101/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1095075626 CMS
Janssen Pharmaceuticals, Inc $22.9601/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078206595 CMS
Novartis Pharmaceuticals Corporation $20.2801/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086873629 CMS
CVRx, Inc. $20.1701/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1128561804 CMS
Novartis Pharmaceuticals Corporation $16.7501/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086873623 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $108,071.18 130
PY2020 $2,502.34 125
PY2021 $2,857.91 162
PY2022 $4,971.90 115
PY2023 $6,776.93 123
PY2024 $9,802.19 134
PY2025 $8,653.69 136

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $453,295.52 22
PY2024 Principal investigator $211,396.43 5
PY2022 Principal investigator $12,373.00 6
PY2020 Principal investigator $44,992.63 6
PY2019 Principal investigator $94,387.74 4

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

22 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $9,101.00 12/15/2025 Non-covered Recipient Entity
Crdvsclr Assn Pllc
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175280955
Principal investigator 1 Janssen Research & Development, LLC $1,848.00 11/21/2025 Non-covered Recipient Entity
Crdvsclr Assn Pllc
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175280771
Principal investigator 1 Amgen Inc. $27,708.08 10/24/2025 Non-covered Recipient Entity
CARDIOVASCULAR ASSOCIATION PLLC DBA VITAL HEART AND VEIN
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants With Elevated Lipoprotein(a) No dispute reported 06/30/2026 1246640003
Principal investigator 1 Amgen Inc. $19,654.08 10/24/2025 Non-covered Recipient Entity
CARDIOVASCULAR ASSOCIATION PLLC DBA VITAL HEART AND VEIN
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Maridebart Cafraglutide on Mortality and Morbidity in Participants Living With Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF) No dispute reported 06/30/2026 1246640005
Principal investigator 1 Amgen Inc. $40,362.16 10/24/2025 Non-covered Recipient Entity
CARDIOVASCULAR ASSOCIATION PLLC DBA VITAL HEART AND VEIN
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity No dispute reported 06/30/2026 1246640007
Principal investigator 1 Janssen Research & Development, LLC $4,183.00 10/22/2025 Non-covered Recipient Entity
Crdvsclr Assn Pllc
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175279784
Principal investigator 1 Janssen Research & Development, LLC $3,385.00 09/19/2025 Non-covered Recipient Entity
Crdvsclr Assn Pllc
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175279204
Principal investigator 1 Janssen Research & Development, LLC $5,440.00 08/25/2025 Non-covered Recipient Entity
Crdvsclr Assn Pllc
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175279138
Principal investigator 1 Amgen Inc. $3,314.33 07/28/2025 Non-covered Recipient Entity
VITAL HEART AND VEIN
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants With Elevated Lipoprotein(a) No dispute reported 06/30/2026 1246651746
Principal investigator 1 Janssen Research & Development, LLC $3,487.00 07/23/2025 Non-covered Recipient Entity
Crdvsclr Assn Pllc
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175280310
Principal investigator 1 Janssen Research & Development, LLC $2,384.00 06/25/2025 Non-covered Recipient Entity
Crdvsclr Assn Pllc
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175280621
Principal investigator 1 Amgen Inc. $11,780.56 06/23/2025 Non-covered Recipient Entity
VITAL HEART AND VEIN
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity No dispute reported 06/30/2026 1246651754
Principal investigator 1 Janssen Research & Development, LLC $9,671.00 06/20/2025 Non-covered Recipient Entity
Crdvsclr Assn Pllc
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175280140
Principal investigator 1 Amgen Inc. $5,118.98 06/12/2025 Non-covered Recipient Entity
VITAL HEART AND VEIN
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Maridebart Cafraglutide on Mortality and Morbidity in Participants Living With Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF) No dispute reported 06/30/2026 1246651750
Principal investigator 1 Janssen Research & Development, LLC $974.00 05/16/2025 Non-covered Recipient Entity
Crdvsclr Assn Pllc
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175280977
Principal investigator 1 Amgen Inc. $63,050.00 04/23/2025 Non-covered Recipient Entity
CARDIOVASCULAR ASSOCIATION, PLLC
The African American Heart Study: A Real-World Data Study of Atherosclerotic Cardiovascular Risk in African American and Black Participants in the US No dispute reported 06/30/2026 1246640009
Principal investigator 1 Janssen Research & Development, LLC $2,384.00 04/23/2025 Non-covered Recipient Entity
Crdvsclr Assn Pllc
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175278821
Principal investigator 1 Janssen Research & Development, LLC $2,181.00 03/17/2025 Non-covered Recipient Entity
Crdvsclr Assn Pllc
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175279945
Principal investigator 1 Janssen Research & Development, LLC $2,384.00 02/24/2025 Non-covered Recipient Entity
Crdvsclr Assn Pllc
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175280601
Principal investigator 1 Amgen Inc. $91,813.63 01/22/2025 Non-covered Recipient Entity
VITAL HEART AND VEIN
The African American Heart Study: A Real-World Data Study of Atherosclerotic Cardiovascular Risk in African American and Black Participants in the US No dispute reported 06/30/2026 1246651758
Principal investigator 1 Janssen Research & Development, LLC $1,078.00 01/22/2025 Non-covered Recipient Entity
Crdvsclr Assn Pllc
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175279089
Principal investigator 1 Bard Peripheral Vascular, Inc. $141,993.70 01/13/2025 Non-covered Recipient Entity
Vital Heart and Vein
AGILITY No dispute reported 06/30/2026 1232158852